We have performed for the first time the simultaneous measurement of the two-body and threebody photodisintegration cross-sections of 4 He in the energy range from 21.8 to 29.8 MeV using monoenergetic pulsed photons and a 4π time projection chamber containing 4 He gas as an active target in an event-by-event mode. The photon beam was produced via the Compton backscattering of laser photons with high-energy electrons. The 4 He(γ,p) 3 H and 4 He(γ,n) 3 He cross sections were found to increase monotonically with energy up to 29.8 MeV, in contrast to the result of a recent theoretical calculation based on the Lorentz integral transform method which predicted a pronounced peak at around 26−27 MeV. The energy dependence of the obtained 4 He(γ,n) 3 He cross section up to 26.5 MeV is marginally consistent with a Faddeev-type calculation predicting a flat pattern of the excitation function. The cross-section ratio of 4 He(γ,p) 3 H to 4 He(γ,n) 3 He is found to be consistent with the expected value for charge symmetry of the strong interaction within the experimental uncertainty in the measured energy range. The present results for the total and two-body crosssections of the photodisintegration of 4 He are compared to previous experimental data and recent theoretical calculations.
Computed Tomography (CT) using X-ray attenuation by atomic effects is now widely used for medical diagnosis and industrial non-destructive inspection. In this study, we performed a tomographic imaging of isotope (208Pb) distribution by the Nuclear Resonance Fluorescence (NRF), i.e. isotope specific resonant absorption and scattering of gamma rays, using Laser Compton Scattering (LCS) gamma rays. The NRF-CT image which includes both effects of atomic attenuation and nuclear resonant attenuation was obtained. By accounting for the atomic attenuation measured by a conventional method at the same time, a clear 208Pb isotope CT image was obtained. The contrast degradation due to notch refilling caused by small-angle Compton scattering is discussed. This study clearly demonstrates the capability of the isotope-specific CT imaging based on nuclear resonant attenuation which will be a realistic technique when the next generation of extremely intense LCS gamma-ray sources will be available. The expected image acquisition time using these intense LCS gamma rays was discussed.
The isotope selectivity of computed tomography (CT) imaging based on nuclear resonance fluorescence (NRF) transmission method using a quasi-monochromatic laser Compton scattering (LCS) gamma-ray beam in the MeV region was demonstrated at the Ultra Violet Synchrotron Orbital Radiation-III (UVSOR-III) Synchrotron Radiation Facility (Institute of Molecular Science, National Institute of Natural Science) for two enriched lead isotope rods (206 Pb and 208 Pb) implanted in an aluminum cylinder. Since these two rods show the same gamma-ray attenuation in atomic processes, it is impossible to differentiate between them using a standard Gamma-CT technique based on atomic attenuation of gamma rays. The LCS gamma-ray beam had a maximum energy of 5.528 MeV and an intensity of approximately 5.5 photons/s/eV at the resonance energy (J π = 1 − at 5.512 MeV in 208 Pb). A lead collimator with a hole diameter of 1 mm was used to define the size of the LCS gamma-ray beam at the CT target. The CT image of the 208 Pb rod was selectively obtained with a 2-mm pixel size resolution, which was determined by the horizontal step size of the CT stage. Index Terms-Computed tomography (CT), isotope distribution, laser Compton scattering (LCS) gamma-ray beam, nuclear resonance fluorescence (NRF). I. INTRODUCTION N ONDESTRUCTIVE assay (NDA) technology, which is used to identify specific isotopes in a substance,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.